Biotransformation of allyl chloride in the rat: Influence of inducers on the urinary metabolic profile

Drug Metabolism and Disposition

Volumn 24, Issue 7, 1996, Pages 765-772

  De Rooij, Ben M ^a   Commandeur, Jan N M ^a   Groot, Ed J ^a   Boogaard, Pieter J ^b   Vermeulen, Nico P E ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b SHELL RESEARCH AND TECHNOLOGY CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3 CHLORO 2 HYDROXYPROPYLMERCAPTURIC ACID; 3 HYDROXYPROPYLMERCAPTURIC ACID; ACETYLCYSTEINE DERIVATIVE; ALLYL CHLORIDE; ALLYL MERCAPTURIC ACID; ALPHA CHLOROHYDRIN; BETA NAPHTHOFLAVONE; BIOCHEMICAL MARKER; CHLOROHYDRIN DERIVATIVE; EPICHLOROHYDRIN; PHENOBARBITAL; PYRAZOLE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BIOTRANSFORMATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENZYME INDUCTION; GAS CHROMATOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY METABOLISM; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

ACETYLCYSTEINE; ALLYL COMPOUNDS; ALPHA-CHLOROHYDRIN; ANIMALS; BETA-NAPHTHOFLAVONE; BIOLOGICAL MARKERS; BIOTRANSFORMATION; CYSTEINE; ENZYME INDUCTION; MALE; RATS; RATS, WISTAR;

EID: 0029679768     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. IARC: Allyl chloride. IARC Monogr. 36, 39-54 (1985).
2. G. D. Nielsen and J. C. Bakbo: Sensory irritating effects of allyl halides and a role for hydrogen bonding as a likely feature at the receptor site. Acta Pharmacol. Toxicol. 57, 106-116 (1985).
3. The Dutch Ministry of Social Affairs: "De Nationale MAC Lijst," Sdu P145. Sdu, The Hague, 1995 (in Dutch).
4. M. Omura, Y. Itonaga, H. Komatsu, Z. Mangen, M. Hirata, A. Tanaka, and N. Inoue: The acute toxicity of allyl chloride by subcutaneous injection in mice. Fukuoka Acta Med. 84, 427-432 (1993).
5. L. Boqin, D. Shuwel, Y. Airu, X. Yinlin, G. Taibao, and C. Tao: Studies on the toxicity of allyl chloride. Ecotoxicol. Environ. Safety 6, 19-27 (1982).
6. M. Nagano, H. Yamamoto, K. Harada, E. Miyamoto, and M. Futatsuka: Comparative study of modification and degradation of neurofilament proteins in rats subchronically treated with allyl chloride, acrylamide, or 2,5-hexanedione. Environ. Res. 63, 229-240 (1993).
7. T. R. Torkelson, M. A. Wolf, F. Oyen, and V. K. Rowe: Vapor toxicity of allyl chloride as determined on laboratory animals. Am. Ind. Hyg. Assoc. J. 20, 217-223 (1959).
8. J. A. John, T. S. Gushow, J. A. Ayres, T. R. Hanley, J. F. Quast, and K. S. Rao: Teratologic evaluation of inhaled epichlorohydrin and allyl chloride in rats and rabbits. Fundam. Appl. Toxicol. 3, 437-442 (1983).
9. B. D. Hardin, G. P. Bond, M. R. Sikov, F. D. Andrew, R. P. Beliles, and R. W. Niemeier: Testing of selected workplace chemicals for teratogenic potential. Scand. J. Work Environ. Health 7 (Suppl. 4), 66-75 (1981).
10. E. C. McCoy, L. Burrows, and H. S. Rosenkranz: Genetic activity of allyl chloride. Mutat. Res. 57, 11-15 (1978).
11. E. Eder, T. Neudecker, and D. Henschler: Correlating of alkylating and mutagenic activities of allyl and allylic compounds: standard alkylation test vs. kinetic investigation. Chem.-Biol. Interact. 38, 303-315 (1982).
12. T. Neudecker and D. Henschler: Mutagenicity of chloro-olefins in the salmonella/mammalian microsome test 1. Allyl chloride mutagenicity re-examined. Mutat. Res. 157, 145-148 (1985).
13. E. Eder, D. Lutz, and M. Jörns: Allylic compounds bind directly to DNA: investigation of the binding mechanisms in vitro. Chem.-Biol. Interact. 61, 97-108 (1987).
14. B. L. van Duuren, B. M. Goldschmidt, G. Leowengart, A. C. Smith, S. Melchionne, I. Seidman, and D. Roth: Carcinogenicity of halogenated olefinic and aliphatic hydrocarbons in mice. J. Natl. Cancer Inst. 63, 1433-1439 (1979).
15. J. C. Theiss, M. B. Shimkin, and L. A. Poirier: Induction of pulmonary adenomas in strain A mice by substituted organohalides. Cancer Res. 39, 391-395 (1979).
16. M. Häusler and R. Lenich: Zur wirkung von allylchlorid bei chronischer gewerblicher exposition. Arch. Toxikol. 23, 209-214 (1968).
17. P. J. Boogaard, P. S. J. Rocchi, and N. J. van Sittert: Effects of low concentrations of chlorinated hydrocarbons on the kidney and liver of industrial workers. Br. J. Ind. Med. 50, 331-339 (1993).
18. H. Fengsheng and Z. Sou-lin: Effects of allyl chloride on occupationally exposed subjects. Scand. J. Work Environ. Health 11 (Suppl. 4), 43-45 (1985).
19. C. M. Kaye, J. J. Clapp, and L. Young: The metabolic formation of mercapturic acids from allyl halides. Xenobiotica 2, 129-139 (1972).
20. R. Sanduja, G. A. S. Ansari, and P. J. Boor: 3-Hydroxypropyl mercapturic acid: a biologic marker of exposure to allylic and related compounds. J. Appl. Toxicol. 9, 235-238 (1989).
21. C. M. Kaye: Biosynthesis of mercapturic acids from allyl alcohol, allyl esters and acrolein. Biochem. J. 134, 1093-1101 (1973).
22. D. K. Stevens, R. J. Bull, C. H. Nauman, and J. Blancato: Decision model for biomarkers of exposure. Reg. Toxicol. Pharmacol. 14, 286-296 (1991).
23. N. P. E. Vermeulen: Analyses of mercapturic acids as a tool in biotransformation, biomonitoring and toxicological studies. Trends Pharmacol. Sci. 10, 177-181 (1989).
24. R. T. H. van Welie, R. G. J. M. van Dijck, N. P. E. Vermeulen, and N. J. van Sittert: Mercapturic acids, protein adducts and DNA adducts as biomarkers of electrophilic chemicals. Crit. Rev. Toxicol. 22, 271-306 (1992).
25. 14C]epichlorohydrin after oral administration to rats. Drug Metab. Dispos. 13, 333-341 (1985).
26. F. Oesch, J. Doehmer, T. Friedberg, H. R. Glatt, B. Oesch-Bartlomowicz, K. L. Platt, P. Steinberg, D. Utesch, and H. Thomas: Toxicological implications of enzyme control of reactive metabolites. Human Exp. Toxicol. 9, 171-177 (1990).
27. W. Onkenhout, E. J. C. van Bergen, J. H. F. van der Wart, G. P. Vos, W. Buijs, and N. P. E. Vermeulen: Identification and quantitative determination of four different mercapturic acids formed from 1,3-dibromopropane and its 1,1,3,3-tetradeutero analogue by the rat. Xenobiotica 16, 21-33 (1986).
28. S. Vamvakas, W. Dekant, K. Berthold, S. Schmidt, D. Wild, and D. Henschler: Enzymatic transformation of mercapturic acids derived from halogenated alkenes to reactive and mutagenic intermediates. Biochem. Pharmacol. 36, 2741-2748 (1987).
29. M. Dressler: Flame photometric detector. J. Chromatogr. Library 36, 133-159 (1986).
30. R. Wittmann: Bestimmung von dichlorpropanolen und monochlorpropandiolen in würzen und würzehaltigen lebensmitteln. Z. Lebensm. Unters. Forsch. 193, 224-229 (1991).
31. D. R. Koop: Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P-450 isoenzyme 3a. Mol. Pharmacol. 29, 399-404 (1986).
32. M. D. Burke, S. Thompson, C. R. Elcombe, J. Halpert, T. Haaparanta, and R. T. Mayer: Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol. 34, 3337-3345 (1985).
33. N. J. van Sittert, P. J. Boogaard, and G. D. J. Beulink: Application of the urinary S-phenylmercapturic acid test as a biomarker for low levels of exposure to benzene in industry. Br. J. Ind. Med. 50, 460-469 (1993).
34. 14C]methyl bromide in Fischer 344 rats after oral or intraperitoneal administration. Toxicology 32, 187-196 (1984).
35. T. Neudecker and D. Henschler: Mutagenicity of chloro-olefins in the salmonella/mammalian microsome test 111: metabolic activation of the allylic chloropropenes allyl chloride, 1,3-dichloropropene, 2,3-dichloro-1 -propene, 1,2,3-trichloropropene, 1,1,2,3-tetrachloro-2-propene and hexachloropropene by S9 mix via two different metabolic pathways. Mutat. Res. 170, 1-9 (1986).
36. J. L. Raucy, J. C. Kraner, and J. M. Lasker: Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit. Rev. Toxicol. 23, 1-20 (1993).
37. J. A. Craft: Effects of pyrazole on nitrosodimethylamine demethylase and other microsomal xenobiotic metabolizing activities. Biochem. Pharmacol. 34, 1507-1513 (1985).
38. K. C. Falkner, G. P. McCallum, and J. R. Bend: Effects of arsenite treatment on NAD(P)H:quinone acceptor oxidoreductase activity in liver, lung, kidney, and heart of rat: comparison to induction by polyaromatic hydrocarbon, β-naphthoflavone. Drug Metab. Dispos. 21, 334-337 (1993).
39. M. C. Larsen, P. B. Brake, D. Parmar, and C. R. Jefcoate: The induction of five rat hepatic P450 cytochromes by phenobarbital and similarly acting compounds is regulated by a sexually dimorphic, dietary-dependent endocrine factor that is highly strain specific. Arch. Biochem. Biophys. 315, 24-34 (1994).
40. Y. Aniya, M. Shimoji, and A. Naito: Increase in liver microsomal glutathione S-transferase activity by phenobarbital treatment of rats. Biochem. Pharmacol. 46, 1741-1747 (1993).
41. P. E. Thomas, L. M. Reik, D. E. Ryan, and W. Levin: Regulation of three forms of cytochrome P-450 and epoxide hydrolase in rat liver microsomes. J. Biol. Chem. 256, 1044-1052 (1981).